Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NVSEF - Olema Pharmaceuticals Starts U.S. IPO Plan

NVSEF - Olema Pharmaceuticals Starts U.S. IPO Plan

Novartis Ag Basel Akt
  • Olema Pharmaceuticals has filed to raise $100 million in an IPO, although the final figure may differ.
  • The firm is advancing its OP-1250 drug to treat various women's cancers as a monotherapy and in combination with other drugs.
  • OLMA has a collaboration deal with Novartis, which is testing OP-1250 in combination with its ribociclib.

For further details see:

Olema Pharmaceuticals Starts U.S. IPO Plan
Stock Information
Company Name: Novartis Ag Basel Akt
Stock Symbol: NVSEF
Market: OTC
Website: novartis.com
Menu
NVSEF NVSEF Quote NVSEF Short NVSEF News NVSEF Articles NVSEF Message Board
Get NVSEF Alerts

News, Short Squeeze, Breakout and More Instantly...